Richard S. Lindahl - 23 Feb 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Financial Officer
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
23 Feb 2023
Net transactions value
-$19,744
Form type
4
Filing time
27 Feb 2023, 19:22:59 UTC
Previous filing
10 Feb 2023
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $6,349 -444 -2.3% $14.30 18,957 23 Feb 2023 Direct F1
transaction EBS Common Stock Tax liability $13,395 -977 -5.2% $13.71 17,980 24 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.